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Background: Fluralaner is a novel isoxazoline eliciting both acaricidal and insecticidal activity through potent blockage
of GABA- and glutamate-gated chloride channels. The aim of the study was to investigate the susceptibility of juvenile
stages of common tick species exposed to fluralaner through either contact (Rhipicephalus sanguineus) or contact and
feeding routes (Ornithodoros moubata).
Methods: Fluralaner acaricidal activity through both contact and feeding exposure was measured in vitro using two
separate testing protocols. Acaricidal contact activity against Rhipicephalus sanguineus life stages was assessed using
three minute immersion in fluralaner concentrations between 50 and 0.05 μg/mL (larvae) or between 1000 and
0.2 μg/mL (nymphs and adults). Contact and feeding activity against Ornithodoros moubata nymphs was assessed
using fluralaner concentrations between 1000 to 10−4 μg/mL (contact test) and 0.1 to 10−10 μg/mL (feeding test).
Activity was assessed 48 hours after exposure and all tests included vehicle and untreated negative control groups.
Results: Fluralaner lethal concentrations (LC50, LC90/95) were defined as concentrations with either 50%, 90% or 95%
killing effect in the tested sample population. After contact exposure of R. sanguineus life stages lethal concentrations
were (μg/mL): larvae - LC50 0.7, LC90 2.4; nymphs - LC50 1.4, LC90 2.6; and adults - LC50 278, LC90 1973. After exposure of
O. moubata nymphs to fluralaner lethal concentrations were (μg/mL): contact exposure - LC50 720, LC95 1133; and
feeding exposure- LC50 0.00007, LC95 0.09.
Conclusions: Fluralaner demonstrates potent in vitro acaricidal activity against all life stages of the brown dog tick,
R.sanguineus. The testing of fluralaner contact and feeding routes using O. moubata nymphs demonstrates a high
acaricidal activity in both exposure routes.
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Fluralaner is a new molecular entity of the isoxazoline
class and provides potent acaricidal and insecticidal ac-
tivity through a dual mechanism of binding to both
neuronal GABA and glutamate channels in susceptible
invertebrates [1,2]. The favorable properties of fluralaner
led to the development of a novel veterinary parasiticide
(Bravecto™, MSD Animal Health), whose remarkably
long duration of activity against tick and flea infestations
after the oral administration to dogs was confirmed in* Correspondence: heike.williams@msd.de
MSD Animal Health Innovation GmbH, Research Antiparasitics, Zur Propstei,
55270 Schwabenheim, Germany
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unless otherwise stated.clinical field studies in different geographic regions of
Europe and the USA [3,4]. Only a short period of time is
needed to effectively kill fleas (8 hours) and ticks (12
hours) on orally treated dogs [5,6]. This rapid speed of
kill lasts for a 12-week period, a benefit for dog owners
with respect to the disruption of the flea life cycle [5,7],
treatment of flea allergy dermatitis (FAD) [3-5] and re-
ducing the risk of pathogen transmission [6].
Due to its selectivity to arthropods, fluralaner has a
very favorable safety profile in dogs [8] including MDR1
(-/-) Collies [9]. It was shown that concurrent treatments
of oral fluralaner with milbemycin oxime – praziquantell. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(Scalibor™ protectorband, MSD Animal Health) [11] is
also well tolerated in dogs.
While fluralaner’s effects on different flea life cycle
stages have already been described [7], more information
regarding the susceptibility of juvenile ticks to fluralaner
is desirable. The studies discussed in this paper were
designed to provide quantitative in vitro data on the sus-
ceptibility of common tick species exposed to fluralaner
through both contact and feeding routes.Methods
All test procedures were conducted on three replicates
per species and life stage (where appropriate) along with
a vehicle control (solvent concentration equivalent to
that of the highest fluralaner concentration test solution)
as well as an untreated negative control.Tick contact exposure of R. sanguineus life stages
A fluralaner stock solution (20 mg/mL) was diluted with
deionized water to a fluralaner concentration of 1000
μg/mL and then further diluted with sufficient volume
of deionized water to obtain the test concentrations be-
tween 50 and 0.05 μg/mL for larvae (i.e. 50, 25, 12.5, 6.2,
3.1, 1.5, 0.78, 0.39, 0.2, 0.1 and 0.05 μg/mL), and bet-
ween 1000 and 0.2 μg/mL for nymphs and adults (i.e.
1000, 500, 100, 50, 25, 12.5, 6.2, 3.1, 1.5, 0.78, 0.39 and
0.2 μg/mL). A sufficient number of R. sanguineus larvae
(i.e. 88-390 per replicate) or nymphs (i.e. 35-115 per rep-
licate) were placed with a brush between two filter pa-
pers in a Petri dish and 5 mL of either test or vehicle
solution was added to immerse the larvae and nymphs
while another group remained untreated. Larvae were
immersed in fluralaner concentrations between 50 and
0.05 μg/mL, while nymphs were immersed in fluralaner
concentrations between 1000 and 0.2 μg/mL. After three
minutes, the solution was poured off and the filter pa-
pers were unfolded and placed with the exterior side on
a paper towel to remove excess solution. All ticks were
then stripped onto a new filter paper that was folded
into a sachet and sealed. Sachets were incubated at
approximately 22°C and 90% relative humidity (RH) for
48 hours. The sachets were then opened and transferred
to a heated plate for counting the number of live and
dead larvae and nymphs.
Adult ticks were tested with fluralaner concentrations
between 1000 and 0.2 μg/mL. Twenty unfed adult ticks
were immersed in 5 mL of either test or negative control
solution in an Erlenmeyer flask for three minutes while
another group remained untreated. Then ticks were
strained from the flask contents, dried on a paper towel,
transferred to dry filter paper in a Petri dish and cov-
ered. Petri dishes were then incubated as for larvae andnymphs, followed by counting the number of live and
dead adults on a heated plate.
Tick contact exposure of O. moubata
A fluralaner stock solution (20 mg/mL) was diluted with
deionized water to a test concentration of 1000 μg/mL
and a series of 1:10 dilutions with deionized water were
prepared to obtain fluralaner test concentrations bet-
ween 1000 and 10−4 μg/mL (i.e. 1000, 100, 10, 1, 0.1,
0.01, 0.001 and 10−4 μg/mL).
Twenty unfed O. moubata nymphs were immersed
in 5 mL of either test or a vehicle solution in an
Erlenmeyer flask for five minutes or nymphs remained
untreated. Ticks were then strained, dried on a paper
towel, transferred into a Petri dish lined with a dry fil-
ter paper and covered. The Petri dish was incubated at
20°C and 95% RH for 48 hours. Thereafter, the number
of live and dead ticks was counted on a heated plate.
Tick membrane feeding exposure of O. moubata
Defibrinated sheep blood was added to a fluralaner stock
solution (50 mg/mL) to produce a 1000 μg/mL fluralaner
preparation that was then further diluted in series of 1:10
with sheep blood to obtain test concentrations between
0.1 and 10−10 μg/mL (i.e. 0.1, 0.01, 0.001, 10−4, 10−5, 10−6,
10−7, 10−8, 10−9 and 10−10 μg/mL).
Twenty O. moubata nymphs were fed using artificial
membranes with either a test or vehicle control prepa-
ration or an untreated control (feeding on blood only)
until engorgement. Ticks were counted and placed into
a plastic vial that was then closed with a stretched
membrane and placed upside down on a glass dish con-
taining 2 mL warmed test or vehicle preparation to per-
mit feeding. Fully engorged ticks were transferred to
dry filter paper in a Petri dish and covered. Ticks were
incubated at 22°C and 90% RH for 48 hours, then the
dishes were opened and numbers of live and dead ticks
counted on a heated plate.
Statistical analysis
The corrected percentages of mortality were calculated
for all test methods, fluralaner concentrations and for
each species and life stage (where appropriate) using
Schneider-Orelli’s formula:
Corrected Mortality %ð Þ ¼ M in treated plot – M in control plotð Þ
= 100 – M in control plotð Þ  100;
where M was the mortality (%) for each tick stage/spe-
cies per concentration tested and included either ticks
from all replicates of the respective test preparation (M
in treated plot) or control preparation (M in control
plot, i.e. the arithmetic mean mortality obtained from
Table 1 R. sanguineus- mortality of different tick life





1000 NT 100 88.5
500 NT 100 58.5
100 NT 100 28.5
50 100 100 6.5
25 100 100 3.5
12.5 100 100 0
6.2 100 100 1.5
3.1 98.9 97.0 3.5
1.5 91.7 54.9 0
0.78 31.0 4.1 0
0.39 9.1 1.1 0
0.20 4.6 0.8 0
0.10 4.7 NT NT
0.05 3.1 NT NT
aThe mortality results were corrected with the mortality in controls (i.e. larvae
3.1%, nymphs 0.7%, adults 0%) using Schneider-Orelli’s formula.
NT: not tested.
Table 3 O. moubata- mortality of nymphs after contact or
feeding exposure to fluralaner
Fluralaner (μg/mL) Mortality (%)a















aThe mortality results were corrected with the mortality in controls (i.e. contact
exposure 0%, feeding exposure 2.5%) using Schneider-Orelli’s formula.
NT: not tested.
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the following formula:
M %ð Þ ¼ arithmetic mean of dead ticks per preparation=
arithmetic mean of ticks used per preparation:
The corrected mortality results were then used to
calculate lethal concentrations LC50 and LC90 or LC95,
defined as concentrations with either 50%, 90% or 95%
killing effect in the tested sample population. Lethal flur-
alaner concentrations for each exposure method were
calculated using probit analysis (SAS®, release 9.2).
Results
Tick contact exposure of R. sanguineus life stages
The arithmetic mean mortality obtained from vehicle
control and untreated control was 3.1% (larvae), 0.7%
(nymphs) and 0% (adults). The corrected R. sanguineus
life stage mortality (Table 1) at 48 hours after contact
exposure to fluralaner were used to calculate predicted
LC50 and LC90 fluralaner concentrations (Table 2). AfterTable 2 Lethal concentrations (LC) of fluralaner for
different tick life stages after contact exposure




Adults 278.04 1973.0fluralaner contact exposure of R. sanguineus LC90 results
were 2.41 μg/mL (larvae), 2.61 μg/mL (nymphs) and
1973 μg/mL (adults).
Tick contact and membrane feeding exposure of
O. moubata
The arithmetic mean mortality obtained from vehicle
control and untreated control was 0% after contact ex-
posure and 2.5% after feeding exposure. The corrected
O. moubata nymph mortality after both contact and
membrane feeding exposure to fluralaner are presented
(Table 3) and predicted LC50 and LC95 fluralaner con-
centrations were calculated (Table 4). After fluralaner
contact and feeding exposure of O. moubata LC95 re-
sults were 1133 μg/mL (contact) and 0.09104 μg/mL
(feeding).
Discussion
The results show that fluralaner has potent acaricidal acti-
vity against two different tick genera that is observed in
both of the in vitro contact and feeding exposure routes
tested.Table 4 Lethal concentrations (LC) of fluralaner for ticks
after contact or feeding exposure
O. moubata Fluralaner (μg/mL)
Exposure method LC50 LC95
Nymphs Contact 719.5 1133.0
Feeding 0.00007 0.09104
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(larvae, nymphs and adults) of R. sanguineus, all of
which feed on dogs, shows that juvenile life stages are
more susceptible to contact fluralaner exposure than
adults, and among the juvenile stages larvae are slightly
more sensitive than nymphs (Table 1). Comparison of
the LC90 results shows that larvae and nymphs are about
700-fold more sensitive to the acaricidal activity of flura-
laner than the adults. The greater acaricidal activity
against juvenile ticks compared with adult ticks offers
additional protection to dogs and their owners, because
fluralaner treated animals that are free of visible adult
ticks are even more likely to be free of smaller, and
therefore more difficult to spot, juvenile ticks. The pro-
minent efficacy demonstrated for fluralaner (Bravecto™)
in a clinical field study supports this conclusion as some
juvenile ticks (Ixodes spp.) were present on dogs when
included into the study [3], indicating the possibility that
dogs were exposed to larval and nymph infestations also
in the further course of the study.
Comparison of the LC values between both exposure
routes tested shows that fluralaner’s acaricidal potency is
greater following feeding exposure than following con-
tact exposure. This result supports that fluralaner can be
highly effective for systemic administration to dogs for
ectoparasite control.
In vitro feeding of argasid (soft) ticks, e.g. Ornithodoros
spp., on blood through ready to use artificial membranes
is a long-established method [12-14] with the advantage
of ticks completing their blood meal within a few hours
[14], and it is an established model at the authors’
laboratory. The method has also been adapted to several
ixodid (hard) tick species [14-16] including the brown
dog tick, R. sanguineus [17]. The drawback, however, is
that the longer feeding duration until repletion of hard
ticks is a challenge [14] and increases the complexity of
the assay compared to soft tick in vitro feeding. One of
the limiting factors of the in vitro feeding of hard ticks
seems to be the length of the tick’s mouthparts [17]. The
attempt to feed larvae of R. sanguineus on bovine blood
through a silicone membrane failed because larvae did
not attach [17]. Taking this into consideration, R. sangui-
neus ticks were evaluated using contact exposure tests
which allowed for a direct comparison of the suscepti-
bility of all three life stages to fluralaner.
After contact exposure, O. moubata exhibits similar
susceptibility to fluralaner as adult R. sanguineus while
juvenile R. sanguineus are even more susceptible. Thus,
O. moubata can serve as a surrogate for R. sanguineus
in the assessment of sensitivity to fluralaner after feeding
exposure.
After feeding exposure to fluralaner, LC95 for O. moubata
is extremely low (<0.1 μg/mL), far lower (around 12,000-
fold) than the contact LC95 suggesting that fluralaner alsohas much greater acaricidal potency against all stages of R.
sanguineus through feeding exposure rather than through
contact exposure. The field study results [3] on client-
owned dogs using oral administration of fluralaner
(Bravecto™) strongly support this observation.
Conclusions
Fluralaner demonstrates potent acaricidal in vitro acti-
vity against all life stages of R. sanguineus. The investi-
gation of contact as well as feeding routes using O.
moubata nymphs underlines the high acaricidal activity
of fluralaner via both exposure routes. Given the fact
that juvenile tick stages are even more susceptible to
fluralaner than adult ticks, this molecule offers the op-
portunity to even more effectively control ticks across
their lifecycle.
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